Respirerx Pharmaceuticals Stock Fundamentals
| RSPIDelisted Stock | USD 0.01 0.00 0.00% |
RespireRx Pharmaceuticals fundamentals help investors to digest information that contributes to RespireRx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of RespireRx Pink Sheet. The fundamental analysis module provides a way to measure RespireRx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RespireRx Pharmaceuticals pink sheet.
RespireRx |
RespireRx Pharmaceuticals Company Return On Asset Analysis
RespireRx Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current RespireRx Pharmaceuticals Return On Asset | -8.34 |
Most of RespireRx Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RespireRx Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, RespireRx Pharmaceuticals has a Return On Asset of -8.3401. This is 4.68% lower than that of the Pharmaceuticals sector and 64.66% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
RespireRx Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RespireRx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare RespireRx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RespireRx Pharmaceuticals competition to find correlations between indicators driving RespireRx Pharmaceuticals's intrinsic value. More Info.RespireRx Pharmaceuticals is rated third in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value RespireRx Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RespireRx Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.RespireRx Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RespireRx Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RespireRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing RespireRx Pharmaceuticals by comparing valuation metrics of similar companies.RespireRx Pharmaceuticals is currently under evaluation in return on asset category among its peers.
RespireRx Fundamentals
| Return On Asset | -8.34 | ||||
| Current Valuation | 3.18 M | ||||
| Shares Outstanding | 119.59 M | ||||
| Shares Owned By Insiders | 20.63 % | ||||
| Number Of Shares Shorted | 126 | ||||
| Price To Earning | (0.25) X | ||||
| Price To Sales | 1,051 X | ||||
| EBITDA | (2.42 M) | ||||
| Net Income | (3.14 M) | ||||
| Cash And Equivalents | 21 | ||||
| Total Debt | 2.42 M | ||||
| Current Ratio | 0.01 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (956.17 K) | ||||
| Short Ratio | 1.47 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.3 | ||||
| Beta | 0.24 | ||||
| Market Capitalization | 837.16 K | ||||
| Total Asset | 208.74 K | ||||
| Retained Earnings | (156.09 M) | ||||
| Working Capital | (4.89 M) | ||||
| Current Asset | 157 K | ||||
| Current Liabilities | 5.05 M | ||||
| Net Asset | 208.74 K |
About RespireRx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RespireRx Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RespireRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RespireRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey. Respirerx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in RespireRx Pink Sheet
If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |